A Proof Of Concept Study To Assess The Steroid Sparing Effect Of Combined Nasal And Inhaled Corticosteroid In Patients With Asthma And Persistent Rhinitis.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluticasone propionate (Primary)
- Indications Allergic rhinitis; Asthma
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 16 Oct 2019 Biomarkers information updated
- 19 May 2009 Additional lead trial centres, investigator, actual end date (Aug 2008), phase (IV) identified as reported by ClinicalTrials.gov.
- 19 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.